Literature DB >> 27350281

Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin.

Lori W Lee1, Neera S Narang2, Anna Postolova2, Nicole Seminara3, Molly A Kantor4,5.   

Abstract

Dermatomyositis is a chronic systemic autoimmune disease characterized by inflammatory infiltrates in the skin and muscle. The wide variability in clinical and serologic presentation poses a diagnostic challenge for the internist. Appreciation of the clinical variants of dermatomyositis allows for expedient diagnosis and avoidance of diagnostic error. We illustrate these challenges with the case of a 51-year-old Vietnamese-American man who initially presented with fever of unknown origin in the absence of overt skin and muscle manifestations. The diagnosis of dermatomyositis was not evident on several clinical encounters due to the absence of these hallmark symptoms. We review the variable clinical manifestations of a subtype of dermatomyositis associated with an autoantibody against melanoma differentiation-associated protein 5 (anti-MDA5) and suggest consideration of dermatomyositis as a diagnosis in patients presenting with systemic illness and markedly elevated ferritin, even in the absence of elevated muscle enzymes and classic autoantibodies.

Entities:  

Keywords:  case report; clinical evaluation; clinical reasoning; clinical vignette; dermatomyositis; diagnosis; errors in clinical reasoning; evaluation; fever of unknown origin; rheumatology

Mesh:

Substances:

Year:  2016        PMID: 27350281      PMCID: PMC5130943          DOI: 10.1007/s11606-016-3769-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  50 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Reducing diagnostic errors through effective communication: harnessing the power of information technology.

Authors:  Hardeep Singh; Aanand Dinkar Naik; Raghuram Rao; Laura Ann Petersen
Journal:  J Gen Intern Med       Date:  2008-04       Impact factor: 5.128

3.  Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.

Authors:  Manabu Fujimoto; Yasuhito Hamaguchi; Kenzo Kaji; Takashi Matsushita; Yuki Ichimura; Masanari Kodera; Naoko Ishiguro; Ikuko Ueda-Hayakawa; Yoshihide Asano; Fumihide Ogawa; Keita Fujikawa; Takuya Miyagi; Eriko Mabuchi; Kenji Hirose; Narihiro Akimoto; Naohito Hatta; Kiyohiro Tsutsui; Akira Higashi; Atsuyuki Igarashi; Mariko Seishima; Minoru Hasegawa; Kazuhiko Takehara
Journal:  Arthritis Rheum       Date:  2012-02

4.  Improving patient care. The cognitive psychology of missed diagnoses.

Authors:  Donald A Redelmeier
Journal:  Ann Intern Med       Date:  2005-01-18       Impact factor: 25.391

5.  Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis.

Authors:  Takahisa Gono; Yasushi Kawaguchi; Takashi Satoh; Masataka Kuwana; Yasuhiro Katsumata; Kae Takagi; Ikuko Masuda; Akiko Tochimoto; Sayumi Baba; Yuko Okamoto; Yuko Ota; Hisashi Yamanaka
Journal:  Rheumatology (Oxford)       Date:  2010-05-23       Impact factor: 7.580

6.  Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.

Authors:  Yuki Ichimura; Takashi Matsushita; Yasuhito Hamaguchi; Kenzo Kaji; Minoru Hasegawa; Yoshinori Tanino; Yayoi Inokoshi; Kazuhiro Kawai; Takuro Kanekura; Maria Habuchi; Atsuyuki Igarashi; Ryosuke Sogame; Takashi Hashimoto; Tomohiro Koga; Ayako Nishino; Naoko Ishiguro; Naoki Sugimoto; Rui Aoki; Noriko Ando; Tetsuya Abe; Takashi Kanda; Masataka Kuwana; Kazuhiko Takehara; Manabu Fujimoto
Journal:  Ann Rheum Dis       Date:  2012-01-17       Impact factor: 19.103

7.  Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.

Authors:  H Gunawardena; L R Wedderburn; J North; Z Betteridge; J Dunphy; H Chinoy; J E Davidson; R G Cooper; N J McHugh
Journal:  Rheumatology (Oxford)       Date:  2008-01-30       Impact factor: 7.580

8.  Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.

Authors:  Z E Betteridge; H Gunawardena; H Chinoy; J North; W E R Ollier; R G Cooper; N J McHugh
Journal:  Ann Rheum Dis       Date:  2008-10-17       Impact factor: 19.103

9.  Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy.

Authors:  Ernesto Trallero-Araguás; Moisés Labrador-Horrillo; Albert Selva-O'Callaghan; Maria Angeles Martínez; Xavier Martínez-Gómez; Eduard Palou; Jose Luis Rodriguez-Sanchez; Miquel Vilardell-Tarrés
Journal:  Medicine (Baltimore)       Date:  2010-01       Impact factor: 1.889

Review 10.  Myositis autoantibodies and clinical phenotypes.

Authors:  Anna Ghirardello; Elisabetta Borella; Marianna Beggio; Franco Franceschini; Micaela Fredi; Andrea Doria
Journal:  Auto Immun Highlights       Date:  2014-08-23
View more
  3 in total

Review 1.  Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.

Authors:  Paige W Wolstencroft; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

2.  Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.

Authors:  Gulnara Mamyrova; Takayuki Kishi; Min Shi; Ira N Targoff; Adam M Huber; Rodolfo V Curiel; Frederick W Miller; Lisa G Rider
Journal:  Rheumatology (Oxford)       Date:  2021-04-06       Impact factor: 7.580

3.  Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis.

Authors:  Sung Soo Ahn; Yong-Beom Park; Sang-Won Lee
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.